On air · 2 of 3 networks
Bentham Science
- eurekaselect.com
- Media, Events & Publishing
- AE
- 368 employees
Bentham Science’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 21. Watch Bentham Science with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 2 | Checked 30 Oct 2026 | See all 21 ads → | ||
| Meta | Not checked | — | |||
| Running | 6 | Ads on the Google Ads Transparency Center | Checked 30 Oct 2026 | Collect them with the API → |
Bentham Science has 2 live LinkedIn ads. We recorded 6 Google ads on 30 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 20 May 2026
🧠 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐏𝐚𝐩𝐞𝐫𝐬 | 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐍𝐞𝐮𝐫𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐥𝐨𝐠𝐲 Current Neuropharmacology, a peer-reviewed journal published by Bentham Science, invites researchers and scholars to submit innovative manuscripts that contribute to the advancement of neuropharmacological research and its translational applications. 📨 𝐒𝐮𝐛𝐦𝐢𝐭 𝐘𝐨𝐮𝐫 𝐌𝐚𝐧𝐮𝐬𝐜𝐫𝐢𝐩𝐭: https://bit.ly/3RzzKzX 𝐄𝐝𝐢𝐭𝐨𝐫-𝐢𝐧-𝐂𝐡𝐢𝐞𝐟: Ferdinando Nicoletti 𝐈𝐦𝐩𝐚𝐜𝐭 𝐅𝐚𝐜𝐭𝐨𝐫: 5.3 | 𝐂𝐢𝐭𝐞𝐒𝐜𝐨𝐫𝐞: 10.0 The journal is supported by an esteemed network of experts, including ICOD Project Filippo Caraci, Giovanni Martinotti, Panagiotis Bargiotas, Marco Scarselli, Konstantinos Palikaras, Massimo Allegri, Agorastos Agorastos, Brian Alldredge, and Craig S. Atwood, Ph.D., ensuring a robust peer-review process and the publication of impactful scientific contributions in neuroscience and pharmacology. #CallForPapers #CurrentNeuropharmacology #Neuropharmacology #Neuroscience #BrainResearch #Pharmacology #Research #ClinicalResearch #BenthamScience
- LINKEDIN · IMAGESince 3 Mar 2026
Research thrives in strong communities Bentham Science brings together scholars, editors, and institutions from around the world to advance scientific knowledge. Follow Bentham Science and stay connected with global research developments.
- LINKEDIN · IMAGESince 17 Feb 2026
𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐢𝐧𝐠 𝐡𝐢𝐠𝐡-𝐢𝐦𝐩𝐚𝐜𝐭 𝐫𝐞𝐯𝐢𝐞𝐰𝐬 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐚𝐥 𝐂𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲? 🔗 𝐒𝐮𝐛𝐦𝐢𝐭 𝐭𝐨 𝐚 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 𝐢𝐧𝐝𝐞𝐱𝐞𝐝 𝐣𝐨𝐮𝐫𝐧𝐚𝐥 𝐰𝐢𝐭𝐡 𝐫𝐚𝐩𝐢𝐝 𝐩𝐞𝐞𝐫 𝐫𝐞𝐯𝐢𝐞𝐰: https://lnkd.in/dXHq5Hzt Mini-Reviews in Medicinal Chemistry an international, peer-reviewed journal by Bentham Science, welcomes concise, high-impact mini-reviews on emerging topics in drug design, pharmacogenomics, toxicology, nanocarriers, and rational drug development. 📈 𝐈𝐦𝐩𝐚𝐜𝐭 𝐅𝐚𝐜𝐭𝐨𝐫: 3.3 | 𝐂𝐢𝐭𝐞 𝐒𝐜𝐨𝐫𝐞: 8.5 🔍𝐊𝐞𝐲 𝐓𝐨𝐩𝐢𝐜𝐬 𝐈𝐧𝐜𝐥𝐮𝐝𝐞: · Drug design & discovery strategies · Synthetic & bioorganic chemistry · Structure–activity relationships (SAR/QSAR) · Natural product–based therapeutics · Nanotechnology & targeted delivery
- LINKEDIN · IMAGESince 9 Feb 2026
🔔 𝐂𝐀𝐋𝐋 𝐅𝐎𝐑 𝐏𝐀𝐏𝐄𝐑𝐒 | 𝐒𝐔𝐁𝐌𝐈𝐓 𝐘𝐎𝐔𝐑 𝐌𝐀𝐍𝐔𝐒𝐂𝐑𝐈𝐏𝐓 𝐍𝐎𝐖 📥 𝐒𝐮𝐛𝐦𝐢𝐭 𝐡𝐞𝐫𝐞: https://lnkd.in/deQ4q2dF ⏳ Unlock 𝟑𝟎% 𝐎𝐅𝐅 with code 𝐁𝐌𝐒𝐋𝐈𝐎𝐟𝐟𝐞𝐫𝟐𝟎𝟐𝟔 valid until 𝐀𝐩𝐫𝐢𝐥 𝟑𝟎, 𝟐𝟎𝟐𝟔. 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐫𝐨𝐧𝐭𝐢𝐞𝐫𝐬 𝐨𝐟 𝐠𝐞𝐧𝐞 𝐚𝐧𝐝 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡? Current Gene Therapy invites researchers to submit original studies and comprehensive reviews exploring the latest breakthroughs in gene transfer, vector innovation, and therapeutic applications for human diseases. 📌 𝐄𝐝𝐢𝐭𝐨𝐫-𝐢𝐧-𝐂𝐡𝐢𝐞𝐟: 𝐃𝐫. 𝐅𝐚𝐧𝐠𝐥𝐢𝐧 𝐆𝐮𝐚𝐧 📅 𝐈𝐦𝐩𝐚𝐜𝐭 𝐅𝐚𝐜𝐭𝐨𝐫: 3.3 | 𝐂𝐢𝐭𝐞 𝐒𝐜𝐨𝐫𝐞: 6.5 We’re proud to work with leading experts like Ignacio Anegon, Yongqun Oliver He, Festenstein, Richard Antonia Follenzi, Mark Tangney, Seng H. Cheng, who guide the journal’s rigorous peer-review process and ensure high-impact content. 🔬 𝐊𝐞𝐲 𝐅𝐨𝐜𝐮𝐬 𝐀𝐫𝐞𝐚𝐬: · Gene and cell therapy applications · Vector design and gene delivery systems · Genetic engineering and molecular medicine · Ethical and translational aspects of therapy #GeneTherapy #CellTherapy #GeneticEngineering #MolecularMedicine #TranslationalResearch #VectorDevelopment #CurrentGeneTherapy #CallForPapers #BenthamScience
- LINKEDIN · IMAGESince 16 Jan 2026
🧠 𝐒𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐥𝐨𝐠𝐲! 𝘾𝙪𝙧𝙧𝙚𝙣𝙩 𝙉𝙚𝙪𝙧𝙤𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙤𝙡𝙤𝙜𝙮, an international, peer-reviewed journal published by 𝘽𝙚𝙣𝙩𝙝𝙖𝙢 𝙎𝙘𝙞𝙚𝙣𝙘𝙚, invites researchers to submit high-quality manuscripts advancing the understanding of neuropharmacology and neuroscience. 📨 𝐒𝐮𝐛𝐦𝐢𝐭 𝐘𝐨𝐮𝐫 𝐌𝐚𝐧𝐮𝐬𝐜𝐫𝐢𝐩𝐭: https://lnkd.in/dC3pXZ5u 📌 𝐄𝐝𝐢𝐭𝐨𝐫-𝐢𝐧-𝐂𝐡𝐢𝐞𝐟: Ferdinando Nicoletti 📈 𝐈𝐦𝐩𝐚𝐜𝐭 𝐅𝐚𝐜𝐭𝐨𝐫: 5.3 | 𝐂𝐢𝐭𝐞 𝐒𝐜𝐨𝐫𝐞: 10.0 We’re proud to collaborate with distinguished experts like ICOD Project Filippo Caraci, Giovanni Martinotti, Panagiotis Bargiotas, Marco Scarselli, Konstantinos Palikaras, Massimo Allegri, Agorastos Agorastos, Brian Alldredge, and Craig S. Atwood, Ph.D., who ensure the rigorous peer-review process and support the publication of impactful, high-quality research. #CallForPapers #Neuropharmacology #Neuroscience #ClinicalResearch #Research #TranslationalMedicine #BenthamScience #AcademicPublishing
- LINKEDIN · IMAGESince 14 Jan 2026
🔬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡 𝐰𝐢𝐭𝐡 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐓𝐨𝐝𝐚𝐲! Reach a global audience with 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, an international, peer-reviewed journal by 𝐁𝐞𝐧𝐭𝐡𝐚𝐦 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 publishing comprehensive reviews, mini-reviews, original research, short communications, and clinical trial studies. 👉 𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗺𝗮𝗻𝘂𝘀𝗰𝗿𝗶𝗽𝘁: https://lnkd.in/dtEH59af #MolecularMedicine #BiomedicalResearch #TranslationalMedicine #DiseaseMechanisms #CallForPapers #SubmitYourResearch #AcademicPublishing #ScientificPublishing #PeerReviewed #CurrentMolecularMedicine #BenthamScience
6 of 21 adsSign up to see every Bentham Science ad, filter by format and date, and get alerts on new ones.
See all 21 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.